Less Ads, More Data, More Tools Register for FREE

Pin to quick picksADVFN Regulatory News (AFN)

  • There is currently no data for AFN

Corporate Update

20 Nov 2017 10:46

RNS Number : 9667W
ADVFN PLC
20 November 2017
 

 

For immediate release

 

20 November 2017 

 

ADVFN PLC

 ("ADVFN" or the "Company")

Corporate Update

 

The Board of ADVFN is pleased to announce that following the success of the MJAC2017 exhibition organised by the Company's US platform, InvestorsHub.com, and launched in Los Angeles during September of this year, ADVFN has formed a new venture: MJAC InvestorsHub International Conferences Limited ("MJAC InvestorsHub"). MJAC InvestorsHub is based in Las Vegas and will develop the MJAC conference and new exhibition opportunities starting with MJAC2018, which will be held in the autumn of 2018 in Las Vegas. USA-based THC Therapeutics, Inc (OTC:THCT) has agreed to take a 50% interest in MJAC InvestorsHub for a cash payment of US$500,000. THC is publicly listed on the US Over-the-Counter market.

 

Clem Chambers CEO of ADVFN said:

 

"After a very pleasing start with the MJAC2017 LA show, MJAC InvestorsHub plans to develop conferences and exhibitions focusing on disruptive technologies including: blockchain, lithium and medical marijuana. Linking up with THC Therapeutics leverages this opportunity with an increased US footprint, finance and enhanced market knowledge."

 

Brandon Romanek CEO of THC Therapeutics, Inc. said:

 

"Having met Clem Chambers, CEO of ADVFN, and spent time with their board of directors as we've worked to establish this partnership, I am very impressed with what they have accomplished and their vision not only for ADVFN, but also our shared vision for MJAC LTD as a leading force in the convention/expo space for these disruptive technologies."

 

 

MJAC2017 was held at the JW Marriot LIVE in Los Angeles in early September 2017 and featured many exhibitors and speakers from the rapidly growing cannabis industry. Further details can be found at https://mjac.io MJAC2017 was a unique environment that allowed industry companies to exhibit their businesses to high net worth investors. As the 'go-to' website for information on MJ Stocks and related investment opportunities, InvestorsHub.com's traffic has been increasing weekly and its forums are actively engaged with insight and opinions from our unique audience.

 

More information on ADVFN can be found at: www.ADVFN.com

 

For further information please contact: 

 

 

ADVFN PLC

Clem Chambers, CEO

 

+44 (0) 207 070 0909

Beaumont Cornish Limited (Nominated Adviser)

www.beaumontcornish.com

Roland Cornish/Felicity Geidt

+44 (0) 207 628 3396

ENDS

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
UPDBBLFLDFFZFBX
Date   Source Headline
11th Jan 202310:49 amRNSHolding(s) in Company
11th Jan 202310:49 amRNSHolding(s) in Company
10th Jan 20237:00 amRNSCorporate update
9th Jan 20235:22 pmRNSTotal voting rights, Director / PDMR shareholding
6th Jan 20232:04 pmRNSFinal Results of Open Offer
6th Jan 20237:00 amRNSResults of Open Offer
20th Dec 20227:00 amRNSOpen Offer timetable and AGM
6th Dec 20227:00 amRNSOpen Offer
6th Dec 20227:00 amRNSFinal Results
28th Nov 20227:00 amRNSCorporate update
15th Sep 202210:45 amRNSAppointment of joint corporate broker
19th Aug 20224:15 pmRNSCorporate update
8th Aug 20227:00 amRNSDirectorate Change
6th Jun 20227:00 amRNSTrading and Corporate Update
29th Apr 20222:05 pmRNSResult of Meeting
28th Apr 20224:41 pmRNSSecond Price Monitoring Extn
28th Apr 20224:35 pmRNSPrice Monitoring Extension
28th Apr 20222:01 pmRNSHolding(s) in Company
22nd Apr 20224:00 pmRNSTotal Voting Rights
20th Apr 202211:05 amRNSSecond Price Monitoring Extn
20th Apr 202211:00 amRNSPrice Monitoring Extension
13th Apr 20229:29 amRNSHolding(s) in Company
4th Apr 202212:25 pmRNSNotice of GM
28th Mar 20228:04 amRNSCorporate Update
22nd Mar 20227:00 amRNSWinners of Financial Awards 2022 Announced
17th Mar 20223:32 pmRNSHolding(s) in Company
17th Mar 20223:32 pmRNSHolding(s) in Company
16th Mar 202210:29 amRNSHolding(s) in Company
9th Mar 20227:00 amRNSCorporate Update
3rd Mar 20225:20 pmRNSCorporate Update
25th Feb 20222:02 pmRNSDirector/PDMR Shareholding
24th Feb 20227:00 amRNSBoard change
23rd Feb 20227:00 amRNSCorporate Update
21st Feb 20227:00 amRNSHalf-year Report
14th Feb 20229:21 amRNSRequisition of general meeting update
8th Feb 202210:54 amRNSStrategic review and end of formal sales process
3rd Feb 202210:47 amRNSForm 8.3 - ADVFN PLC
26th Jan 20221:15 pmRNSRequisition of General Meeting
26th Jan 20227:00 amRNSBest Global Private Investor Multi-Market Informat
24th Jan 20229:35 amRNSForm 8.3 - ADVFN plc
21st Jan 20223:14 pmRNSForm 8.3 - ADVFN plc
19th Jan 20225:03 pmRNSForm 8.3 - ADVFN plc
19th Jan 20224:53 pmRNSForm 8.3 - ADVFN PLC
18th Jan 20227:00 amRNSForm 8 (OPD) ADVFN plc
13th Jan 20227:00 amRNSStrategic review and formal sales process
29th Dec 20215:19 pmRNSHolding(s) in Company
29th Dec 20215:15 pmRNSHolding(s) in Company
23rd Dec 20213:28 pmRNSResult of AGM
22nd Nov 20211:08 pmRNSHolding(s) in Company - Replacement
22nd Nov 202111:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.